Jim Joyce

Jim Joyce

Chief Executive Officer at SIGYN THERAPEUTICS, INC.

Net worth: 11 859 $ as of 30/06/2026

64 year
Health Technology
Consumer Services
Distribution Services

Profile

Mr. Jim A. Joyce is a Chairman & Chief Executive Officer at Sigyn Therapeutics, Inc. Mr. Joyce was previously employed as a Chief Executive Officer & Director by Reign Resources Corp., an Executive Chairman by Exosome Sciences, Inc., a Chief Executive Officer, Secretary & Director by Aethlon Medical, Inc., a Chairman & Chief Executive Officer by Mission Labs, Inc., a Member by Denver Broncos Team LLC, a Chief Financial Officer by Innovative Health Monitoring LLC, a Chief Executive Officer by James Joyce & Associates, a Principal by London Zurich Securities, Inc., and a Chairman & Chief Executive Officer by Sigyn Therapeutics, Inc. /Old/.
He received his undergraduate degree from the University of Maryland.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/04/2025 320,500 ( 19.96% ) 11 859 $ 30/06/2026

Jim Joyce active positions

CompaniesPositionStart
SIGYN THERAPEUTICS, INC. Chief Executive Officer 19/10/2019

Former positions of Jim Joyce

CompaniesPositionEnd
AETHLON MEDICAL, INC. Chief Executive Officer 10/12/2018
Founder 01/01/2018
Mission Labs, Inc.
Chief Executive Officer 01/01/1991
Director of Finance/CFO -
Corporate Officer/Principal -
See the detail of Jim Joyce's experience

Training of Jim Joyce

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

71

1st degree connections

11

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies11

Health Technology

Consumer Services

Consumer Services

James Joyce & Associates

Mission Labs, Inc.

Health Technology

Distribution Services

London Zurich Securities, Inc.

Electronic Technology

Health Technology

Health Technology